IDO1 and neoplasm: In addition to terminating immune tolerance, d-1-MT can also block the dormancy of tumor-repopulating cells (TRCs) and induce apoptosis through the IDO1-blocking/P53/reactive oxygen species (ROS)-mediated pathway (105).